Sinopharm
1099.HK
#2863
Rank
NZ$10.43 B
Marketcap
NZ$3.34
Share price
-0.07%
Change (1 day)
-17.31%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: NZ$4.26 Billion

According to Sinopharm's latest financial reports the company's current earnings are NZ$82.21 Billion. In 2025 the company made an earning of NZ$4.26 Billion, an increase over its 2024 earnings that were of NZ$4.00 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025NZ$4.26 B6.59%
2024NZ$4.00 B-27.86%
2023NZ$5.55 B-0.73%
2022NZ$5.59 B-1.72%
2021NZ$5.69 B11.7%
2020NZ$5.09 B18.44%
2019NZ$4.30 B10.85%
2018NZ$3.88 B3.05%
2017NZ$3.76 B36.48%
2016NZ$2.75 B7.11%
2015NZ$2.57 B12.38%
2014NZ$2.29 B25.05%
2013NZ$1.83 B22.54%
2012NZ$1.49 B35.43%
2011NZ$1.10 B52.24%
2010NZ$0.72 B30.99%
2009NZ$0.55 B60.59%
2008NZ$0.34 B48.29%
2007NZ$0.23 B123.29%
2006NZ$0.10 B